Diagnostics & Tools January 2020

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Blueprint Genetics acquired by Quest Diagnostics
• Andrew Alliance to be acquired by Waters Corporation
• Insight Genetics to be acquired by OncoCyte
• NeXtal Biotechnologies acquired by CalibreScientific